The UC San Diego Moores Cancer Center has renewed its NCI core grant, securing $25 million over five years. - Clinical trial activation time dropped from 224 days in 2018 to 86.5 days in April 2025.
- Patient enrollment in interventional trials increased by 250%. - The center treats a high number of high-risk patients and ranks 41st nationally.
- Patient satisfaction is rated 'above average,' but some report appointment delays. The renewal ensures continued federal support for the region's only comprehensive cancer center.